A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
Kura Oncology, Inc.
Kura Oncology, Inc.
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
University of Washington
St. Jude Children's Research Hospital
Vanderbilt-Ingram Cancer Center
Wake Forest University Health Sciences
Wake Forest University Health Sciences
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital